Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy

Fig. 6

Western blot analyses of the expression levels of bax, cleaved caspase 3, Parp, LC3 and MDR1 proteins in cells after treatments. *P < 0.05, vs the bax protein expression of controlled group, #P < 0.05, vs the cleaved caspase 3 protein expression of controlled group, P < 0.05, vs the cleaved parp expression of controlled group, P < 0.05, vs the LC3 II/LC I expression of controlled group, P < 0.05, vs the MDR1 expression of controlled group, data were presented as mean ± SD (n = 3)

Back to article page